# SION (Sionna Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Sionna Therapeutics, Inc. reported $263.3M in total assets and a net loss of $109.5M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/SION
- Markdown: https://convexityos.com/fundamentals/SION.md
- SEC CIK: 0002036042
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:46 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002036042&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$120.5M | Operating profit |
| Net Income | FY 2025 | -$109.5M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.42 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$79.61M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $83.88M | Total debt: $7.75M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Research & Development | $60.26M | $57.29M |
| Total Operating Expenses | $88.98M | $70.56M |
| **Operating Income** | -$88.98M | -$70.56M |
| **EBITDA** | -$88.33M | -$69.89M |
| Interest Income | $13.29M | $8.17M |
| Income Tax Expense | $0 | $0 |
| **Net Income** | -$75.27M | -$61.69M |
| Basic EPS | -$1.88 | -$15.99 |
| **Diluted EPS** | -$1.88 | -$15.99 |
| Basic Shares Outstanding | 40.0M | 3.9M |
| Diluted Shares Outstanding | 40.0M | 3.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $22.02M | $21.86M | $18.96M | $15.17M | $16.04M | $15.38M | $13.67M | $14.25M |
| Total Operating Expenses | $34.82M | $32.47M | $29.60M | $23.61M | $23.80M | $21.91M | $19.66M | $18.13M |
| **Operating Income** | -$34.82M | -$32.47M | -$29.60M | -$23.61M | -$23.80M | -$21.91M | -$19.66M | -$18.13M |
| **EBITDA** | -$34.62M | -$32.27M | -$29.45M | -$23.46M | -$23.70M | -$21.81M | -$19.50M | -$17.97M |
| Interest Income | $2.41M | $2.59M | $2.82M | $3.17M | $3.46M | $3.67M | $3.00M | $2.12M |
| **Net Income** | -$32.42M | -$29.89M | -$26.78M | -$20.44M | -$20.28M | -$18.07M | -$16.48M | -$15.85M |
| Basic EPS | -$0.72 | -$0.66 | -$0.60 | -- | -$0.46 | -$0.41 | -$0.62 | -- |
| **Diluted EPS** | -$0.72 | -$0.66 | -$0.60 | -- | -$0.46 | -$0.41 | -$0.62 | -- |
| Basic Shares Outstanding | 45.2M | 45.1M | 44.9M | -- | 44.3M | 44.1M | 26.6M | -- |
| Diluted Shares Outstanding | 45.2M | 45.1M | 44.9M | -- | 44.3M | 44.1M | 26.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $58.45M | $37.79M |
| **Cash & Short-Term Investments** | $58.45M | $37.79M |
| **Total Current Assets** | $241.4M | $151.0M |
| Property, Plant & Equipment, Net | $2.23M | $2.47M |
| Other Non-Current Assets | $0 | $2.99M |
| **Total Non-Current Assets** | $84.53M | $34.76M |
| **Total Assets** | $326.0M | $185.8M |
| Accounts Payable | $769K | $1.19M |
| Other Current Liabilities | $6.0K | $0 |
| **Total Current Liabilities** | $11.71M | $10.42M |
| **Total Non-Current Liabilities** | $7.41M | $8.68M |
| **Total Liabilities** | $19.12M | $19.10M |
| **Total Debt (incl. Leases)** | $8.68M | $9.75M |
| Common Stock | $45K | $5.0K |
| Retained Earnings | -$256.4M | -$181.1M |
| Accumulated Other Comp. Income | $540K | $368K |
| **Total Stockholders' Equity** | $306.8M | -$163.7M |
| Total Equity | $306.8M | -$163.7M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $83.88M | $63.32M | $63.32M | $58.45M | $50.83M | $40.98M | $82.69M | $37.79M |
| **Cash & Short-Term Investments** | $249.8M | $268.3M | $289.9M | $58.45M | $325.0M | $337.3M | $354.7M | $37.79M |
| **Total Current Assets** | $228.5M | $216.1M | $221.0M | $241.4M | $252.3M | $266.7M | $273.7M | $151.0M |
| Property, Plant & Equipment, Net | $1.76M | $1.92M | $2.07M | $2.23M | $2.14M | $2.25M | $2.39M | $2.47M |
| Other Non-Current Assets | $638K | $594K | $585K | $0 | $0 | $0 | $0 | $2.99M |
| **Total Non-Current Assets** | $34.73M | $67.12M | $84.08M | $84.53M | $86.94M | $85.30M | $95.99M | $34.76M |
| **Total Assets** | $263.3M | $283.2M | $305.0M | $326.0M | $339.3M | $352.0M | $369.7M | $185.8M |
| Accounts Payable | $1.05M | $523K | $2.11M | $769K | $1.48M | $914K | $5.02M | $1.19M |
| Other Current Liabilities | $0 | $7.0K | $17K | $6.0K | $224K | -- | -- | $0 |
| **Total Current Liabilities** | $16.42M | $10.78M | $9.78M | $11.71M | $9.85M | $7.55M | $9.53M | $10.42M |
| **Total Non-Current Liabilities** | $6.32M | $6.69M | $7.05M | $7.41M | $7.75M | $8.07M | $8.38M | $8.68M |
| **Total Liabilities** | $22.74M | $17.47M | $16.83M | $19.12M | $17.60M | $15.62M | $17.91M | $19.10M |
| **Total Debt (incl. Leases)** | $7.75M | $8.07M | $8.38M | $8.68M | $8.97M | $9.24M | $9.50M | $9.75M |
| Common Stock | $45K | $45K | $45K | $45K | $44K | $44K | $44K | $5.0K |
| Retained Earnings | -$345.4M | -$313.0M | -$283.1M | -$256.4M | -$235.9M | -$215.6M | -$197.6M | -$181.1M |
| Accumulated Other Comp. Income | -$723K | -$448K | -$84K | $540K | $420K | $183K | $301K | $368K |
| **Total Stockholders' Equity** | $240.5M | $265.8M | $288.2M | $306.8M | $321.7M | $336.4M | $351.8M | -$163.7M |
| Total Equity | $240.5M | $265.8M | $288.2M | $306.8M | $321.7M | $336.4M | $351.8M | -$163.7M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | -$75.27M | -$61.69M |
| Depreciation & Amortization | $647K | $668K |
| Stock-Based Compensation | $12.07M | $3.71M |
| Change in Payables | -$417K | $467K |
| **Operating Cash Flow** | -$66.30M | -$52.79M |
| Capital Expenditure | -$377K | -$27K |
| **Free Cash Flow** | -$66.67M | -$52.81M |
| Purchases of Investments | -$325.0M | -$182.8M |
| **Investing Cash Flow** | -$118.7M | -$126.9M |
| **Financing Cash Flow** | $205.7M | $179.0M |
| **Net Change in Cash** | $20.66M | -$733K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$32.42M | -$29.89M | -$26.78M | -$20.44M | -$20.28M | -$18.07M | -$16.48M | -$15.85M |
| Depreciation & Amortization | $200K | $200K | $154K | $152K | $100K | $100K | $159K | $167K |
| Stock-Based Compensation | $7.08M | $6.84M | $6.55M | $3.83M | $3.31M | $2.84M | $2.09M | $1.06M |
| Change in Payables | $604K | -$1.53M | $1.21M | -$712K | $567K | -$3.83M | $3.55M | $1.08M |
| **Operating Cash Flow** | -$18.72M | -$22.22M | -$21.84M | -$16.63M | -$15.23M | -$18.15M | -$16.29M | -$11.78M |
| Capital Expenditure | $0 | $0 | $0 | -$204K | -$87K | $0 | -$86K | -$27K |
| **Free Cash Flow** | -$18.72M | -$22.22M | -$21.84M | -$16.83M | -$15.32M | -$18.15M | -$16.37M | -$11.81M |
| Purchases of Investments | -$11.35M | -$33.03M | -$25.33M | -$42.88M | -$54.14M | -$56.42M | -$171.6M | -$7.20M |
| **Investing Cash Flow** | $38.95M | $21.47M | $24.82M | $22.59M | $23.10M | -$23.25M | -$141.2M | $15.23M |
| **Financing Cash Flow** | $333K | $749K | $1.89M | $1.66M | $1.97M | -$312K | $202.4M | -$1.41M |
| **Net Change in Cash** | $20.56M | -$2.0K | $4.87M | $7.62M | $9.85M | -$41.71M | $44.91M | $2.04M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Return on Equity (ROE) | -24.5% | -- |
| Return on Assets (ROA) | -23.1% | -33.2% |
| Current Ratio | 20.61x | 14.49x |
| Quick Ratio | 4.99x | 3.63x |
| Debt to Equity | 0.03x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -45.5% | -36.6% | -29.7% | -24.5% | -22.0% | -22.5% | -18.9% | -- |
| Return on Assets (ROA) | -41.6% | -34.4% | -28.1% | -23.1% | -20.8% | -21.5% | -17.9% | -33.2% |
| Current Ratio | 13.92x | 20.05x | 22.60x | 20.61x | 25.61x | 35.33x | 28.73x | 14.49x |
| Quick Ratio | 15.21x | 24.88x | 29.65x | 4.99x | 32.99x | 44.68x | 37.23x | 3.63x |
| Debt to Equity | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
